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Many effectors secreted by pathogenic bacteria suppress host signal transduction pathways that activate
host defense responses. In this issue of Cell Host & Microbe, Zhou et al. (2011) now broaden that theme
by demonstrating that HopZ1b from Pseudomonas syringae pv. glycinea causes degradation of a host
enzyme directly involved in the synthesis of antimicrobial phytoalexin compounds.Study of highly conserved pathogen
effectors can reveal the host functions
that animal or plant pathogens have the
greatest need to overcome. In this issue,
Zhou et al. (2011) report a new type of
target for effector biologists—plant isofla-
vonoid metabolism—and thereby reignite
interest in an old and at times contentious
research area regarding the host defense
arsenal: phytoalexins. Phytoalexins are
plant secondary metabolites with direct
antimicrobial activity, whose synthesis is
induced by pathogen infection. The
authors show that the effector HopZ1b
directly interacts with and reduces the
levels of the soybean GmHID1 gene
product 2-hydroxyisoflavanone dehydra-
tase, the enzyme previously shown to
convert 2-hydroxyisoflavanones to isofla-
vones and thereby synthesize the phyto-
alexin precursors daidzein and genistein.
By also demonstrating greater pathogen
growth in plants with partially silenced
GmHID1 expression, Wenbo Ma and
colleagues establish a link between isofla-
vonoid biosynthesis and antibacterial
defense—suggesting that some bacterial
effectors can act by directly disrupting
the synthesis of antimicrobial compounds
(see for comparison Gala´n, 2009; Torto-
Alalibo et al., 2010). However, alternative
roles remain possible for the impacted
isoflavone compounds.
The main subject of the study, effector
HopZ1b, has been present in all tested
strains of ‘‘Pgy’’—the common soy-
bean pathogen Pseudomonas syringae
pv. glycinea (Ma et al., 2006). HopZ1b
and/or the closely related HopZ1a are
also present in Pseudomonas syringae
pathogens of other plants, and are
members of the large and well-studied
YopJ family of effectors from animal andplant bacterial pathogens. These effec-
tors carry signature His, Glu, andCys resi-
dues at the catalytic core, similar to
known cysteine proteases, but in at least
some cases they have been demon-
strated to act as acetyltransferases rather
than cysteine proteases (Mukherjee et al.,
2007). Mutation of one or more catalytic
core residues generally eliminates func-
tion, and can furnish a valuable negative
control in experiments. Previous work
had shown that Pgy bacteria lacking an
active HopZ1b multiply less well in
soybean leaves (Zhou et al., 2009). Study
of HopZ1a, a close sibling of HopZ1b, re-
called a related broad trend. In that trend,
identification of the pathogen functions
that are recognized by a plant’s R gene-
mediated immune system can reveal the
pathogen effectors that the pathogen
most greatly benefits from. Plant R genes
encode immune receptors (often NB-LRR
or NLR proteins) that recognize the
presence of specific pathogen effector
molecules and activate strong defenses,
reversing any prior benefit that the
pathogen gained from that effector. Pgy
bacteria expressing HopZ1a trigger
a strong defense response in many
soybeans, suggesting the presence of a
host R gene system that blocks the utility
of that wing of the pathogen HopZ1
arsenal (Zhou et al., 2009).
The authors took a straightforward
approach to initiate the present study,
using HopZ1 proteins in yeast two-hybrid
experiments to identify potential host
targets (Zhou et al., 2011). They found
that in yeast, in vitro, and in heterologous
plant assays, HopZ1a or HopZ1b can
physically interact with the soybean iso-
flavone biosynthesis enzyme 2-hydroxyi-
soflavanone dehydratase (GmHID1Cell Host & Microbeproduct). Significantly, they found that
active (but not inactive) HopZ1a or
HopZ1b cause degradation of the
GmHID1 protein, when expressed in
Nicotiana benthamiana or Arabidopsis
cells. The expression of GmHID1 is upre-
gulated after Pgy infection, as is the
synthesis of its product daidzein, one of
themain isoflavones of soybean. Daidzein
is the immediate precursor of glyceollin,
the most prominent phytoalexin of
soybean, whose antimicrobial activities
have been documented for decades
(Hammerschmidt 1999). In the important
final section of the study, Zhou et al.
show that artificial silencing of GmHID1
causes soybeans to allow more growth
of pathogenic Pgy, as well as more
growth of nonpathogenic P. syringae
strains. Has the reputation of phytoalexins
just received a significant boost?
Phytoalexins were one of the most
prominent early discoveries about the
molecular basis of plant immune systems
(Hammerschmidt 1999; Naoumkina
et al., 2010). However, it has been notori-
ously difficult to document the signifi-
cance of their contribution to prevention
of disease. Attention to phytoalexins also
may have dwindled becausemanipulation
of their abundance for greater plant
disease resistance in food plants alters
multiple plant flavonoid secondarymetab-
olites—many of which have demonstrable
impacts on human health. With HopZ1b
are the pathogens again tipping their
hand, suggesting that phytoalexinsmatter
and that getting rid of them can enhance
pathogen success? Perhaps, but other
interpretations of the data are possible:
the advantage of reduced daidzein
production may be due to other presently
unknown roles of isoflavonoids. The9, March 17, 2011 ª2011 Elsevier Inc. 169
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pushing the phytoalexin angle, and they
note the intriguing alternative that daidzein
or related compounds may regulate host
defense or pathogen virulence (for exam-
ples, see Bednarek and Osbourn, 2009;
and Mandal et al., 2010). In addition,
HopZ1 effectors may have multiple
targets, and it is possible that the main
raison d’etre of HopZ1b is suppression of
other host targets. It seems unlikely that
the biochemical activity of marking
GmHID1 for degradation has been sus-
tained without evolutionary selective
advantage, especially in light of the data
showing improved bacterial growth on
plants with reduced GmHID1 expression.
But even if GmHID1 degradation is
HopZ1b’s primary function, it remains to
be directly shown whether or not phyto-
alexin suppression is the main benefit
conferred by HopZ1b.170 Cell Host & Microbe 9, March 17, 2011 ªHence, in future work, along with deter-
mining whether HopZ1b is an acetyltrans-
ferase as opposed to a cysteine protease,
three broader questions will be important
to address. Does HopZ1b reduce the
abundance of the phytoalexins that
constrain bacterial growth in the natural
infection court?What are the other targets
of HopZ1b? Do soybean isoflavones play
other roles in defense induction or modu-
lation of bacterial virulence, separate from
any direct antimicrobial activity? Regard-
less of the answers, Ma’s group has
established a new category in the known
repertoire of bacterial effectors, and pro-
vided incentive for renewed attention to
an old friend: plant phytoalexins.REFERENCES
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The early establishment of a reservoir of latently infected T cells is a sobering obstacle to HIV eradication, in
spite of the efficacy of current antiretroviral therapies. That latent proviruses might also hide in multipotent
hematopoietic stem cells suggests an even more formidable challenge and potentially has therapeutic
implications.Quiescent T cells have long been known to
represent thequantitativelymost important
latent HIV reservoir (Finzi et al., 1997).
Because a fully resting T lymphocyte is
not permissive to the early steps of viral
replication, current models postulate that
after HIV infects T cells activated by
antigen- or cytokine-mediated stimulation,
some of these subsequently return to
quiescence, notably as long-term memory
T lymphocytes, where the provirus
becomes silent. The T cell-based HIV
reservoir is established from the earliest
times of infection and is maintained in
partbyhomeostaticproliferation (Chomontet al., 2009). Although its size may be
reduced when highly active antiretroviral
therapy (HAART) is initiated very early,
mathematical models predict that viral
eradication could take up to several
decadesunder conditionsofcompleteviral
suppression (Rong and Perelson, 2009).
Last year, Kathleen Collins and
colleagues reported that HIV-1 can infect
andkillmultipotenthematopoieticprogen-
itor cells (Carter et al., 2010). They also
noted that in a fraction of these cells,
infection was not lethal, but led to latent
proviruses, the expression of which was
reactivated by myeloid differentiation.Furthermore, suggesting the clinical rele-
vance of this observation, they demon-
strated that cells positive for CD34, a
marker of hematopoietic progenitor cells,
whichwere purified from the bonemarrow
of HIV-infected individuals could be
induced by cytokines to produce virus,
even when isolated from patients whose
viremia had been efficiently HAART-sup-
pressed for extensive times.
Following up on these results, Carter
et al. now report an important caveat
(Carter et al., 2011). Indeed, they found
that not all HIV strains can infect early
blood progenitors, only those bearing
